Status:

COMPLETED

Proton MRS Study of SSRI-Zolpidem Interactions

Lead Sponsor:

Mclean Hospital

Collaborating Sponsors:

Brain & Behavior Research Foundation

Conditions:

Depression

Eligibility:

All Genders

21-40 years

Phase:

EARLY_PHASE1

Brief Summary

The primary goal of this single-blind, placebo-controlled, within-subjects, double-scan, one-visit neuroimaging study is to examine the effects of the hypnotic zolpidem (Ambien®) in individuals who ar...

Detailed Description

Sleep disturbances are a primary complaint in at least 35% of depressed patients, and upwards of one third of individuals taking selective serotonin reuptake inhibitors (SSRIs) to treat major depressi...

Eligibility Criteria

Inclusion

  • Participant Eligibility Criteria
  • Participants will be male and female volunteers between the ages of 21-40 recruited via newspaper advertisements and web-based bulletin boards
  • Participants will meet DSM-IV criteria for major depressive disorder, but they cannot meet criteria for any other major psychiatric disorders
  • With the exception of certain short-term anti fungal agents, some topical creams for dermal conditions, and birth control pills, participants cannot be taking any prescription medication other than stable (i.e., ≥ 3 weeks) fluoxetine (≤ 40 mg/day; Prozac), sertraline (≤ 100 mg/day; Zoloft), citalopram (≤ 40 mg/day; Celexa), or paroxetine (≤ 40 mg/day; Paxil)
  • Non-smoking participants are preferred, but will admit those who smoke less than 5 cigarettes per day
  • Participants cannot have a history of major head trauma resulting in cognitive impairment.
  • Participants cannot have any conditions that are contraindicated for MRI
  • Participants cannot have any abnormal blood chemistries or urinalysis results or any current or history of cardiac problems

Exclusion

    Key Trial Info

    Start Date :

    May 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2012

    Estimated Enrollment :

    14 Patients enrolled

    Trial Details

    Trial ID

    NCT01809626

    Start Date

    May 1 2010

    End Date

    December 1 2012

    Last Update

    March 13 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    McLean Hospital

    Belmont, Massachusetts, United States, 02478